Summary
Factor VII (FVII) activity should be measured in order to evaluate the risk for coronary artery disease. The measurement of FVII by means of a standardized clotting method seems to be influenced by the thromboplastins used, while the FVII-deficient plasmas do not affect the results.
Article PDF
Avoid common mistakes on your manuscript.
References
Dalaker K., Hjermann I., Prydz H.: A novel form of factor VII in plasma from men at risk for cardiovascular disease — Brit. J. Haematol.61, 315, 1985.
Hoffman C., Shah A., Sodums M., Hultin M. B.: Factor VII activity state in coronary artery disease — J. Lab. clin. Med.111, 475, 1988.
Kannel W. B., Wolf P. A., Castelli W. P., D’Agostino R. B.: Fibrinogen and risk of cardiovascular disease. The Framingham Study — J. Amer. med. Ass.258, 1183, 1987.
Meade T. W., Mellows S., Brozovic M., Miller G. J., Chakrabarti R. R., North W. R. S., Haines A. P., Stirling Y., Imeson J. D., Thompson S. G.: Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study — Lancetii, 533, 1986.
Meade T. W., North W. R. S., Chakrabarti R. R., Stirling Y., Haines A. P., Thompson S. G.: Haemostatic function and cardiovascular death: early results of a prospective study — Lanceti, 1050, 1980.
Miller G. J., Martin J. C., Webster J., Wilkes H., Miller N. E., Wilkinson W. H., Meade T. W.: Association between dietary fat intake and plasma factor VII coagulant activity — a predictor of cardiovascular mortality — Atherosclerosis60, 269, 1986.
Miller G. J., Walter S. J., Stirling Y., Thompson S. G., Esnouf M. P., Meade T. W.: Assay of factor VII activity by two techniques: evidence for increased conversion of VII to α-VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease — Brit. J. Haematol.59, 249, 1985.
Poggio M., Tripodi A., Mariani G., Mannucci P. M.: Evaluation of a standard clotting method for factor VII measurement — Thrombos. Haemostas. (Submitted for publication).
Scarabin P. Y., Bara I., Samama M., Orssaud G.: Further evidence that activated factor VII is related to plasma lipid — Brit. J. Haematol.61, 177, 1985.
Wilhelmsen L., Svärdsudd K., Korsan-Bengtssen K., Larsson B., Welin L., Tibblin G.: Fibrinogen as a risk factor for stroke and myocardial infarction — New Engl. J. Med.311, 501, 1984.
Author information
Authors and Affiliations
Additional information
For the CISMEL (Comitato Italiano per la Standardizzazione dei Metodi in Ematologia e Laboratorio) Hemostasis Subcommittee.
Rights and permissions
About this article
Cite this article
Poggio, M. Specific assays of hemostasis proteins: Factor VII. Res. Clin. Lab. 20, 139–141 (1990). https://doi.org/10.1007/BF02877560
Issue Date:
DOI: https://doi.org/10.1007/BF02877560